Katarina Smilkov
About
In The Last Decade
Katarina Smilkov
22 papers receiving 453 citations
Peers
Comparison fields: 5 of 100
- Public Health, Environmental and Occupational Health 129
- Molecular Biology 86
- Physiology 76
- Food Science 67
- Rheumatology 56
Countries citing papers authored by Katarina Smilkov
This map shows the geographic impact of Katarina Smilkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Smilkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Smilkov more than expected).
Fields of papers citing papers by Katarina Smilkov
This network shows the impact of papers produced by Katarina Smilkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Smilkov. The network helps show where Katarina Smilkov may publish in the future.
Co-authorship network of co-authors of Katarina Smilkov
This figure shows the co-authorship network connecting the top 25 collaborators of Katarina Smilkov. A scholar is included among the top collaborators of Katarina Smilkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarina Smilkov. Katarina Smilkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 15 | |
| 3 | 7 | |
| 4 | 39 | |
| 5 | 4 | |
| 6 | 4 | |
| 7 | 135 | |
| 8 | 30 | |
| 9 | 1 | |
| 10 | 16 | |
| 11 | Physicochemical Evaluation of Lyophilized Formulation of p-SCN-Bn-DOTA- and p-SCN-Bn-DTPA-rituximab for NHL Radio Immunotherapy. | 0 |
| 12 | Implementation of ISO 17025 Standard and accreditation process of Radiopharmacy Laboratory | 1 |
| 13 | 2 | |
| 14 | EVALUATION OF NON-RADIOACTIVE LUTETIUM- AND YTTRIUM-LABELED IMMUNOCONJUGATES OF RITUXIMAB - A VIBRATIONAL SPECTROSCOPY STUDY | 2 |
| 15 | Anti-inflammatory properties of L. casei loaded wheyprotein-alginate microparticles in animal model of colitis | 1 |
| 16 | 22 | |
| 17 | Rituximab-immunoconjugate kit-formulations for NHL radioimmunotherapy | 0 |
| 18 | Formulation and Characterization of "Ready to Use" 1B4M-DTPA-rituximab for Lu-177 Labeling | 2 |
| 19 | Comparative Evaluation of Viability of Encapsulated Lactobacillus casei Using Two Different Methods of Microencapsulation | 5 |
| 20 | 20 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.